Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
US12016915B2 · kind B2 · utility
0Cited by
23References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2021 |
| Grant date | Jun 25, 2024 |
| Priority date | — |
| Expiry date | Feb 18, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention includes compositions and methods for making and using anti DC-ASGPR antibodies that can, e.g., activate DCs and other cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.